Practice guidelines are patient care strategies developed to assist physicians in clinical decision making. They are developed based on the degree of public importance, relevance to psychiatric practice, availability of information and relevant data, availability of work already done that could be useful in its development, and degree to which increased psychiatric attention in that area would be helpful to the field. Enduring materials developed under practice guidelines meet the needs of advancing clinical knowledge and enriching and expanding the skills of psychiatrists with the ultimate goal of improving patient care.
- General Member - $50.00
- Resident-Fellow Member - $25.00
- Non-Member - $100.00
- Educate physicians with the APA Practice Guideline for the Treatment of Patients With Obsessive-Compulsive Disorder
- Improve patient care for obsessive-compulsive disorders by incorporating the principles of this guideline into individual practices
Clinicians who treat patients with obsessive-compulsive disorders and psychiatrists interested in the latest research findings and clinical approaches to individuals with obsessive-compulsive disorders.
Estimated Time to Complete
Estimated Time to Complete: 8 hours
Activity Release Date: September 2007
Activity Review Date: March 2017
Activity End Date: April 30, 2020
How to Earn Credit
Participants who wish to earn AMA PRA Category 1 Credit™ or a certificate of participation may do so by completing all sections of the course including the evaluation. A multiple choice quiz is provided based on the content. A passing score of 60% must be achieved. Retakes are available for the test. After evaluating the program, course participants will be provided with an opportunity to claim hours of participation and print an official CME certificate (physicians) or certificate of participation (non-physicians) showing the date of completion and hours earned.
Continuing Education Credit
The American Psychiatric Association (APA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The APA designates this enduring CME activity for a maximum of 8.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Faculty and Planners
- Andrea Allen, Ph.D., Assistant Professor, Department of Psychiatry, Compulsive and Impulsive Disorders Program, Mount Sinai School of Medicine, New York. Reports no financial relationships with commercial interests.
- Bernardo Dell'Osso, M.D., Postdoctoral Research Fellow, Department of Psychiatry, Compulsive and Impulsive Disorders Program, Mount Sinai School of Medicine; Department of Clinical Sciences, "L. Sacco" Hospital, University of Milan, Italy. Reports no financial relationships with commercial interests.
- Laura J. Fochtmann, M.D., Practice Guidelines Medical Editor, American Psychiatric Association, and Professor, Department of Psychiatry and Behavioral Sciences and Department of Pharmacological Sciences, State University of New York at Stony Brook. Reports no financial relationships with commercial interests.
- John S. McIntyre, M.D., Chair, APA Steering Committee on Practice Guidelines. Reports no financial relationships with commercial interests.
- Deborah J. Hales, M.D., Former Director, APA Divison of Education. Reports no financial relationships with commercial interests.
- Lorrin Koran, M.D., Professor (Clinical) of Psychiatry and Behavioral Sciences, Emeritus, Stanford School of Medicine, Stanford, CA. Dr. Koran discloses Speakers Bureau, Forest Pharmaceutical, Inc; Consultant, Hoffmann La Roche, Ltd. D
Disclosure of Unapproved or Investigational Use of a Product
APA policy requires disclosure of unapproved or investigational uses of products discussed in CME programs. As of the date of publication of this CME program, the U.S. Food and Drug Administration had approved clomipramine, fluoxetine, fluvoxamine, paroxetine, and sertraline for the treatment of patients with OCD. All uses of other medications to treat OCD are "off-label." All uses of other medications to treat OCD are "off-label." Off-label use the medications by individual physicians is permitted and common. Decisions about off-label use can be guided by the evidence provided in the APA practice guideline, other scientific literature, and clinical experience.
Optimal System Configuration:
- Flash Player: Adobe Flash Player 10.3+
- Browser: Firefox (latest version), Internet Explorer 8.0+, Safari 7.0+, Microsoft Edge (latest version) or Google Chrome (latest version)
- Operating System: Windows XP+ or Mac OS X 10.4+
- Internet Connection: 1 Mbps or higher
- Windows PC: 500-MHz Pentium II; Windows XP or higher; 128 MB RAM; Video Card at least 64MB of video memory; Macromedia Flash Player 10.3 or higher; Sound Card at least 16-bit; audio playback with speakers for programs with video content
- Macintosh:Mac OS X 10.4+ or higher with latest updates installed; 1.83MHz Intel Core Duo or faster; RAM: 128MB or more; Video Card: at least 64MB of video memory; Sound Card: at least 16-bit; audio playback with speakers for programs with video content
For assistance: Contact firstname.lastname@example.org for questions about this course | Contact email@example.com for technical assistance